Index S&P 500
P/E -
EPS (ttm) -10.82
Insider Own 2.73%
Shs Outstand 491.41M
Perf Week 2.36%
Market Cap 20.89B
Forward P/E 14.41
EPS next Y 2.95
Insider Trans -0.35%
Shs Float 478.11M
Perf Month 1.75%
Enterprise Value -
PEG -
EPS next Q -1.22
Inst Own 95.24%
Short Float 2.56%
Perf Quarter 20.19%
Income -5.29B
P/S 0.11
EPS this Y -71.63%
Inst Trans -3.01%
Short Ratio 1.72
Perf Half Y 62.19%
Sales 185.86B
P/B 1.00
EPS next Y 45.01%
ROA -6.43%
Short Interest 12.23M
Perf YTD 3.30%
Book/sh 42.63
P/C -
EPS next 5Y -16.25%
ROE -21.93%
52W High 66.81 -36.37%
Perf Year -33.61%
Cash/sh -
P/FCF 6.23
EPS past 3/5Y 40.38% 14.96%
ROIC -13.74%
52W Low 25.08 69.53%
Perf 3Y -43.51%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y 8.98% 16.92%
Gross Margin -
Volatility 3.08% 3.56%
Perf 5Y -27.23%
Dividend TTM -
EV/Sales -
EPS Y/Y TTM -286.72%
Oper. Margin 0.60%
ATR (14) 1.59
Perf 10Y 41.72%
Dividend Ex-Date -
Quick Ratio -
Sales Y/Y TTM 14.92%
Profit Margin -2.85%
RSI (14) 45.80
Recom 2.74
Dividend Gr. 3/5Y - -
Current Ratio 1.08
EPS Q/Q -1091.35%
SMA20 -5.62%
Beta 0.49
Target Price 43.12
Payout 0.00%
Debt/Eq 0.84
Sales Q/Q 18.24%
SMA50 2.01%
Rel Volume 0.92
Prev Close 42.80
Employees 60500
LT Debt/Eq 0.84
Earnings Feb 06 BMO
SMA200 3.62%
Avg Volume 7.11M
Price 42.51
IPO Dec 13, 2001
Option/Short Yes / Yes
EPS/Sales Surpr. 445.30% 4.12%
Trades
Volume 6,558,993
Change -0.68%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-26 Upgrade
Barclays
Equal Weight → Overweight
$54
Oct-14-25 Initiated
Goldman
Sell
$33
Jul-28-25 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$38
Jul-23-25 Downgrade
Wells Fargo
Overweight → Equal Weight
$30
Jul-21-25 Downgrade
TD Cowen
Buy → Hold
$33
Jul-16-25 Downgrade
BofA Securities
Neutral → Underperform
$30
Jul-10-25 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$33
Jul-02-25 Downgrade
UBS
Buy → Neutral
$45
Jul-02-25 Downgrade
JP Morgan
Overweight → Neutral
$48
Jun-09-25 Resumed
Morgan Stanley
Overweight
$70
Jun-02-25 Downgrade
Barclays
Overweight → Equal Weight
$65
Apr-08-25 Upgrade
Jefferies
Underperform → Hold
$64
Feb-06-25 Downgrade
Argus
Buy → Hold
Dec-17-24 Resumed
JP Morgan
Overweight
$80 → $75
Dec-13-24 Upgrade
UBS
Neutral → Buy
$79 → $80
Dec-10-24 Downgrade
Jefferies
Hold → Underperform
$68 → $52
Jul-24-24 Downgrade
Jefferies
Buy → Hold
$83 → $69
May-30-24 Initiated
Robert W. Baird
Neutral
$83
Mar-21-24 Downgrade
Stephens
Overweight → Equal-Weight
$92 → $85
Mar-06-24 Initiated
Barclays
Overweight
$101
Show Previous Ratings
Today 12:36PM
03:08AM
Feb-02-26 08:54AM
08:29AM
Feb-01-26 07:47AM
07:38AM
Loading…
Jan-31-26 07:38AM
Jan-29-26 08:30AM
02:19AM
Jan-28-26 12:03PM
10:31AM
08:01AM
(Investor's Business Daily)
Jan-27-26 04:44PM
04:44PM
04:34PM
04:13PM
(The Wall Street Journal)
12:55PM
Loading…
12:55PM
12:20PM
11:15AM
10:39AM
10:35AM
(The Wall Street Journal)
10:07AM
09:55AM
08:52AM
07:17AM
07:16AM
(Investor's Business Daily)
07:15AM
(The Wall Street Journal)
03:18AM
(The Wall Street Journal)
Jan-26-26 11:35PM
10:16PM
10:16PM
08:00AM
Loading…
Jan-22-26 08:00AM
Jan-21-26 01:29PM
Jan-20-26 09:48AM
Jan-19-26 09:33AM
07:38AM
Jan-16-26 10:47AM
Jan-15-26 03:10PM
12:04PM
08:00AM
Jan-13-26 04:30PM
05:30AM
(The Wall Street Journal)
Jan-08-26 12:21PM
Jan-07-26 08:00AM
Jan-06-26 11:04AM
07:04AM
Jan-05-26 12:16PM
11:08AM
07:15AM
Jan-01-26 11:05PM
Dec-30-25 10:16AM
Dec-29-25 08:12PM
Dec-23-25 09:08AM
Dec-22-25 11:33PM
Dec-19-25 08:45AM
Dec-17-25 03:01PM
01:00PM
10:56AM
(Investor's Business Daily)
09:10AM
07:11AM
(Investor's Business Daily)
07:11AM
(Investor's Business Daily)
Dec-16-25 04:01PM
02:10PM
(Investor's Business Daily)
03:56AM
Dec-15-25 12:35PM
Dec-12-25 03:22PM
(Investor's Business Daily)
Dec-11-25 11:35PM
03:00PM
01:08PM
11:41AM
Dec-09-25 11:33PM
Dec-04-25 07:37AM
Dec-03-25 07:51AM
Dec-02-25 09:39AM
Nov-28-25 05:30PM
11:30AM
08:50AM
Nov-26-25 11:00AM
Nov-25-25 03:47PM
10:17AM
(Investor's Business Daily)
09:01AM
Nov-24-25 04:21PM
(Investor's Business Daily)
04:12PM
02:34PM
12:22PM
11:27AM
11:03AM
09:35AM
09:16AM
Nov-23-25 05:30AM
(The Wall Street Journal)
Nov-20-25 02:44PM
11:05AM
09:41AM
Nov-19-25 11:30AM
Nov-18-25 04:46PM
Nov-15-25 01:02PM
Nov-14-25 06:02PM
09:39AM
Nov-13-25 11:00AM
Nov-12-25 03:17PM
01:10PM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Burdick Kenneth A Director Dec 03 '25 Sale 39.04 33,211 1,296,557 305,161 Dec 05 05:06 PM Burdick Kenneth A Director Dec 04 '25 Sale 39.00 32,796 1,279,044 272,365 Dec 05 05:06 PM Burdick Kenneth A Director Dec 04 '25 Proposed Sale 39.00 32,796 1,279,044 Dec 04 04:39 PM Burdick Kenneth A Director Dec 03 '25 Proposed Sale 39.04 33,211 1,296,621 Dec 03 04:59 PM Wayne S DeVeydt Director Oct 15 '25 Proposed Sale 35.84 5,489 196,737 Oct 15 03:29 PM DeVeydt Wayne S Director Sep 09 '25 Proposed Sale 29.19 10,775 314,545 Sep 09 01:55 PM LONDON SARAH Chief Executive Officer Aug 08 '25 Buy 25.50 19,230 490,365 845,275 Aug 11 05:28 PM Samuels Theodore R. II Director Jul 28 '25 Buy 27.62 9,000 248,580 32,000 Jul 29 06:01 PM FASOLA KENNETH J Officer Mar 21 '25 Proposed Sale 59.06 8,500 501,970 Mar 21 10:37 AM